Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Protagonist Therapeutics, Inc | d310331dex321.htm |
| EX-31.2 - EX-31.2 - Protagonist Therapeutics, Inc | d310331dex312.htm |
| EX-31.1 - EX-31.1 - Protagonist Therapeutics, Inc | d310331dex311.htm |
| EX-21.1 - EX-21.1 - Protagonist Therapeutics, Inc | d310331dex211.htm |
| EX-10.9 - EX-10.9 - Protagonist Therapeutics, Inc | d310331dex109.htm |
| 10-K - FORM 10-K - Protagonist Therapeutics, Inc | d310331d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-213120) of Protagonist Therapeutics, Inc. of our report dated March 7, 2017 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, CA
March 7, 2017